Go Pro

Urogen Pharma (URGN) Institutional Ownership

Urogen Pharma logo
$39.51 +0.95 (+2.46%)
Closing price 07/13/2026 04:00 PM Eastern
Extended Trading
$39.46 -0.05 (-0.13%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Urogen Pharma (NASDAQ:URGN)

Current
Institutional Ownership
Percentage
91.29%
Number of
Institutional Buyers
(last 12 months)
87
Total
Institutional Inflows
(last 12 months)
$349.71M
Number of
Institutional Sellers
(last 12 months)
50
Total
Institutional Outflows
(last 12 months)
$122.88M
Get URGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Urogen Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

URGN Institutional Buying and Selling by Quarter

Urogen Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/9/2026 Hennion & Walsh Asset Management Inc.276,696$10.18M0.3%+50.8%0.568%
5/26/2026Glenmede Trust Co. NA10,517$189K0.0%N/A0.022%
5/19/2026Bank of America Corp DE126,783$2.28M0.0%-1.4%0.260%
5/19/2026Janus Henderson Group PLC19,100$343K0.0%N/A0.039%
5/19/2026Ally Bridge Group NY LLC202,124$3.63M2.9%N/A0.415%
5/18/2026ADAR1 Capital Management LLC395,459$7.11M0.4%+139.1%0.812%
5/18/2026California State Teachers Retirement System38,750$697K0.0%+1,605.5%0.080%
5/18/2026Elmind Capital LP220,000$3.96M1.1%+120.0%0.452%
5/16/2026The Manufacturers Life Insurance Company 10,909$196K0.0%-80.4%0.022%
5/16/2026Quantinno Capital Management LP20,176$363K0.0%-14.2%0.041%
5/15/2026Rice Hall James & Associates LLC285,834$5.14M0.3%+1.4%0.587%
5/14/2026Healthcare of Ontario Pension Plan Trust Fund387,074$6.96M0.0%-65.6%0.794%
5/13/2026Cetera Investment Advisers29,096$523K0.0%-3.3%0.060%
5/7/2026Swiss National Bank77,800$1.40M0.0%N/A0.160%
4/29/2026Meitav Investment House Ltd.22,223$400K0.0%-37.4%0.046%
4/16/2026SG Americas Securities LLC1,657,846$29.81M0.0%+20.3%3.406%
3/20/2026Hsbc Holdings PLC10,316$236K0.0%-25.7%0.021%
2/19/2026Invesco Ltd.27,066$634K0.0%+21.1%0.058%
2/18/2026XTX Topco Ltd22,491$527K0.0%-23.2%0.048%
2/18/2026Voloridge Investment Management LLC435,490$10.20M0.0%-36.7%0.930%
2/18/2026Susquehanna Portfolio Strategies LLC27,380$641K0.0%N/A0.058%
2/18/2026Tang Capital Management LLC350,000$8.20M0.4%-65.0%0.748%
2/18/2026Superstring Capital Management LP718,354$16.82M9.0%+717.1%1.535%
2/18/2026Orbimed Advisors LLC875,487$20.50M0.4%+27.1%1.870%
2/18/2026Opaleye Management Inc.268,423$6.29M0.8%N/A0.573%
2/18/2026Millennium Management LLC618,952$14.50M0.0%-59.1%1.322%
2/18/2026Main Street Financial Solutions LLC20,990$492K0.0%-34.8%0.045%
2/18/2026Elmind Capital LP100,000$2.34M0.7%N/A0.214%
2/18/2026Cinctive Capital Management LP16,991$398K0.0%N/A0.036%
2/17/2026AQR Capital Management LLC153,413$3.59M0.0%-24.9%0.328%
2/17/2026Cetera Investment Advisers30,096$705K0.0%-6.2%0.064%
2/17/2026MPM Bioimpact LLC941,378$22.05M2.5%+597.3%2.011%
2/17/2026Paradigm Biocapital Advisors LP4,473,648$104.77M2.7%+6.1%9.557%
2/17/2026Jump Financial LLC17,900$419K0.0%-82.8%0.038%
2/17/2026Price T Rowe Associates Inc. MD616,606$14.44M0.0%+72.9%1.317%
2/17/2026Diadema Partners LP21,810$511K0.1%-75.8%0.047%
2/17/2026Russell Investments Group Ltd.47,257$1.11M0.0%+1,323.0%0.101%
2/17/2026Atom Investors LP234,423$5.49M0.4%-19.7%0.501%
2/17/2026ExodusPoint Capital Management LP35,393$829K0.0%+113.9%0.076%
2/17/2026Royal Bank of Canada8,391$196K0.0%-81.5%0.018%
Your book is inside (Ad)

The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel

2/17/2026Persistent Asset Partners Ltd12,806$300K0.1%-38.2%0.027%
2/17/2026Rice Hall James & Associates LLC281,876$6.60M0.4%+8.8%0.602%
2/16/2026Squarepoint Ops LLC22,831$535K0.0%N/A0.049%
2/16/2026Panagora Asset Management Inc.74,055$1.73M0.0%-59.8%0.158%
2/16/2026MML Investors Services LLC24,363$571K0.0%N/A0.052%
2/16/2026Healthcare of Ontario Pension Plan Trust Fund1,125,100$26.35M0.0%N/A2.404%
2/16/2026Barclays PLC57,744$1.35M0.0%+3.8%0.123%
2/13/2026Marshall Wace LLP16,300$382K0.0%-12.7%0.035%
2/13/2026The Manufacturers Life Insurance Company 55,686$1.29M0.0%+55.0%0.119%
2/13/2026Morgan Stanley2,562,901$60.02M0.0%+1.4%5.475%
2/13/2026State Street Corp807,421$18.91M0.0%-1.5%1.725%
2/13/2026Wells Fargo & Company MN84,158$1.97M0.0%-33.2%0.180%
2/12/2026HRT Financial LP130,899$3.07M0.0%-2.1%0.280%
2/12/2026Orion Porfolio Solutions LLC9,008$211K0.0%-18.2%0.019%
2/12/2026Renaissance Technologies LLC244,300$5.72M0.0%-11.2%0.522%
2/12/2026Annandale Capital LLC60,552$1.42M0.2%-14.2%0.129%
2/12/2026Informed Momentum Co LLC160,412$3.76M0.4%N/A0.343%
2/12/2026New York State Common Retirement Fund12,737$298K0.0%+62.5%0.027%
2/12/2026Nuveen LLC302,601$7.09M0.0%-40.4%0.646%
2/11/2026ARK Investment Management LLC121,484$2.85M0.0%-4.1%0.260%
2/11/2026Deutsche Bank AG366,680$8.59M0.0%+126.0%0.783%
2/11/2026Franklin Resources Inc.16,745$392K0.0%N/A0.036%
2/11/2026JPMorgan Chase & Co.146,271$3.43M0.0%-72.6%0.312%
2/11/2026WINTON GROUP Ltd13,188$309K0.0%N/A0.028%
2/10/2026TD Asset Management Inc80,188$1.88M0.0%+82.2%0.171%
2/10/2026Goldman Sachs Group Inc.459,722$10.77M0.0%+8.2%0.982%
2/10/2026Intech Investment Management LLC22,210$520K0.0%+45.9%0.047%
2/9/2026Geode Capital Management LLC475,212$11.13M0.0%+0.8%1.015%
2/6/2026ProShare Advisors LLC8,812$206K0.0%N/A0.019%
2/5/2026DNB Asset Management AS16,961$397K0.0%N/A0.036%
2/3/2026Privium Fund Management B.V.214,622$5.03M0.9%+9.2%0.458%
2/2/2026Oppenheimer & Co. Inc.16,962$397K0.0%N/A0.036%
1/29/2026UBS Group AG235,040$5.51M0.0%+30.2%0.502%
1/29/2026China Universal Asset Management Co. Ltd.7,627$179K0.0%-5.9%0.016%
1/26/2026Mirae Asset Global Investments Co. Ltd.2,275$53K0.0%+27.2%0.005%
1/23/2026Oak Ridge Investments LLC85,230$2.00M0.1%-2.6%0.182%
1/14/2026 Hennion & Walsh Asset Management Inc.161,924$3.79M0.1%+148.4%0.346%
1/9/2026SG Americas Securities LLC1,377,647$32.26M0.0%+19.0%2.943%
1/1/2026JPMorgan Chase & Co.534,545$10.66M0.0%+36.9%1.142%
11/17/2025Jacobs Levy Equity Management Inc.21,376$426K0.0%N/A0.046%
11/17/2025TCG Crossover Management LLC717,347$14.31M0.7%N/A1.532%
11/17/2025XTX Topco Ltd29,302$585K0.0%N/A0.063%
11/17/2025Voloridge Investment Management LLC687,475$13.72M0.0%N/A1.469%
11/17/2025Verition Fund Management LLC89,028$1.78M0.0%N/A0.190%
11/17/2025Paradigm Biocapital Advisors LP4,216,084$84.11M2.4%N/A9.007%
11/17/2025Parkman Healthcare Partners LLC402,595$8.03M0.8%+127.8%0.860%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.17,017$339K0.0%-15.8%0.036%
11/17/2025HighVista Strategies LLC31,886$636K0.2%N/A0.068%
11/17/2025Farallon Capital Management LLC11,000$219K0.0%N/A0.023%
11/17/2025Bank of America Corp DE108,454$2.16M0.0%-59.1%0.232%
Gates. Google. The Pentagon. (Ad)

Bill Gates wrote a $100 million check. Google signed a 15-year contract. The Pentagon named it their top energy priority. All three are backing the same company - and the same energy source that holds 140 times global electricity demand. Last year a drilling crew cracked through three miles of solid rock in 16 days - the government had projected 64. On August 18th, Washington is handing this technology a tax credit advantage that solar and wind no longer receive.tc pixel

See the company Gates, Google, and the Pentagon are all backing
11/14/2025Creative Planning10,444$208K0.0%N/A0.022%
11/14/2025Schonfeld Strategic Advisors LLC297,851$5.94M0.0%+36.3%0.636%
11/14/2025Man Group plc10,780$215K0.0%-24.5%0.023%
11/14/2025Orbimed Advisors LLC689,000$13.75M0.3%+44.0%1.472%
11/14/2025Two Sigma Investments LP386,203$7.71M0.0%+103.9%0.825%
11/13/2025Jump Financial LLC103,866$2.07M0.0%N/A0.222%
11/13/2025Annandale Capital LLC70,552$1.41M0.2%-6.6%0.151%
11/13/2025UBS Group AG180,460$3.60M0.0%-41.5%0.386%
11/13/2025BNP Paribas Financial Markets308,328$6.15M0.0%+328.7%0.659%
11/13/2025Russell Investments Group Ltd.3,321$66K0.0%+1,594.4%0.007%


URGN Institutional Ownership - Frequently Asked Questions

During the previous two years, 155 institutional investors and hedge funds held shares of Urogen Pharma. The most heavily invested institutionals were Paradigm Biocapital Advisors LP ($104.77M), Morgan Stanley ($60.02M), UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC ($48.23M), Jefferies Financial Group Inc. ($43.88M), RTW Investments LP ($40.84M), RA Capital Management L.P. ($35.46M), and Cowen AND Company LLC ($35.23M).Learn more on Urogen Pharma's institutional investors.

91.29% of Urogen Pharma's stock is owned by institutional investors. Learn more on URGN's institutional investor holdings.

Of the 136 institutional investors that purchased Urogen Pharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Paradigm Biocapital Advisors LP ($4.47M), Toronto Dominion Bank ($3.50M), RA Capital Management L.P. ($3.21M), UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC ($3.04M), Soleus Capital Management L.P. ($2.19M), Vestal Point Capital LP ($2.15M), and SG Americas Securities LLC ($1.66M).

Institutional investors have bought a total of 18,197,912 shares in the last 24 months. This purchase volume represents approximately $349.71M in transactions.

Of the 50 institutional investors that sold Urogen Pharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Menora Mivtachim Holdings LTD. ($1.15M), Millennium Management LLC ($894.79K), Healthcare of Ontario Pension Plan Trust Fund ($738.03K), Tang Capital Management LLC ($650K), Adage Capital Partners GP L.L.C. ($447K), JPMorgan Chase & Co. ($388.27K), and Harel Insurance Investments & Financial Services Ltd. ($291.21K).

Institutional investors have sold a total of 6,394,480 shares in the last 24 months. This volume of shares sold represents approximately $122.88M in transactions.



This page (NASDAQ:URGN) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners